Package 71335-2902-1

Brand: cholestyramine powder for suspension

Generic: cholestyramine powder for suspension
NDC Package

Package Facts

Identity

Package NDC 71335-2902-1
Digits Only 7133529021
Product NDC 71335-2902
Description

368.76 g in 1 CAN (71335-2902-1)

Marketing

Marketing Status
Marketed Since 2025-11-07
Brand cholestyramine powder for suspension
Generic cholestyramine powder for suspension
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2800a72a-4af8-461b-952f-8237b2d6e535", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["848943"], "spl_set_id": ["408ad775-9a1b-43cc-b122-226ade73e0c2"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "368.76 g in 1 CAN (71335-2902-1)", "package_ndc": "71335-2902-1", "marketing_start_date": "20251107"}], "brand_name": "cholestyramine powder for suspension", "product_id": "71335-2902_2800a72a-4af8-461b-952f-8237b2d6e535", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "71335-2902", "generic_name": "cholestyramine powder for suspension", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cholestyramine powder for suspension", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/8.78g"}], "application_number": "ANDA211856", "marketing_category": "ANDA", "marketing_start_date": "20211020", "listing_expiration_date": "20271231"}